Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation2007 · 799 citations
2. 2Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity2007 · 150 citations
3. 3Catalytic Activity Is Not Required for Secreted PCSK9 to Reduce Low Density Lipoprotein Receptors in HepG2 Cells2007 · 281 citations
4. 4Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice1998 · 672 citations
5. 5Immunologic cross-reactivity of the low density lipoprotein receptor from bovine adrenal cortex, human fibroblasts, canine liver and adrenal gland, and rat liver.1981 · 68 citations